OR WAIT 15 SECS
The American Society of Health Systems Pharmacists recently published Anticoagulation Therapy: A Point-of-Care Guide for clinicians, pharmacists, and pharmacy residents.
The American Society of Health-System Pharmacists (ASHP) recently published Anticoagulation Therapy: A Point-of-Care Guide for clinicians, pharmacists, and pharmacy residents.
“Anticoagulants, developed to save lives by preventing and treating thrombosis, can also be dangerous. [The guide] is a concise reference that can help pharmacists protect their patients from dangerous adverse drug events,” announced a statement from ASHP.
For example, more than 8% of hospitalized patients on warfarin and more than 13% of hospitalized patients exposed to heparin experience an adverse drug event, according to the Anticoagulation Therapy guide.
The book was edited by William Dager, PharmD, FCSHP, FCCP, a clinical professor of pharmacy at the University of California, San Francisco School of Pharmacy and clinical professor of medicine at University of California, Davis School of Medicine; Michael Gulseth, PharmD, BCPS, program director for anticoagulation services at the Sanford University of South Dakota Medical Center in Sioux Falls, S.D.; and Edith Nutescu, PharmD, FCCP, clinical professor in the Department of Pharmacy Practices and Center for Pharmacoeconomic Research at the University of Illinois, Chicago College of Pharmacy.
The book is divided into 3 sections: Anticoagulation Medication Management, Conditions Requiring Anticoagulation Therapy, and Practical Monitoring and Coagulation Laboratory Insights.
To order the book, visit